SIRT1 activators of different types can mitigate the progression of PD neuropathology through the regulation of oxidative stress, inflammatory disorders, mitochondrial dysfunction, apoptosis, and inflammatory signaling pathways (Cuyàs et al. 2018). Here, SIRT1 is linked to Parkinson disease.